Dublin, Oct. 11, 2016 -- Research and Markets has announced the addition of the "Global Oxidative Stress Detection Market 2016-2020" report to their offering.
The global oxidative stress detection market to grow at a CAGR of 9.28% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global oxidative stress detection market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of instruments, reagents, and services provided for oxidative stress detection process. The report also includes a discussion of the key vendors operating in this market.
Over the past decade, a number of new methods that help in detecting, measuring, and studying oxidative stress in live cells have been introduced. ELISA and flow cytometry, along with the relatively newer technologies, are being used to detect oxidative stress in the body, as well as other key vitals and composition details. In the last four years, the trend has shifted from changes in measuring instruments to incremental innovations in the reagents and consumables segment. In 2016, a new salimetrics uric acid assay kit was introduced. It is capable of high-efficiency oxidative stress research, with non-invasive saliva sampling making the process easier and faster. These new methods of detection and the development of new reagents and consumables will open doors to new possibilities of non-invasive detection of oxidative stress in the body.
According to the report, one of the key drivers for market growth will be rapid growth of end-user industries. The primary end-users of oxidative stress assays are the healthcare industry, pharmaceutical industry, and research institutes. The global pharmaceutical industry will grow at a CAGR of 8.8% between 2015 and 2020, with growing investments in drug discovery and detection. Within the pharmaceutical industry, biopharmaceutical and biotechnology sectors are the major users of oxidative stress assays.
The biopharmaceutical sector will grow at a CAGR of 9.8%, followed by biotechnology with 8.6% during the forecast period. Another area of importance for oxidative stress detection is healthcare diagnostics, which has been gaining importance over the past five years and improving its infrastructure since 2010 in most countries. The steady growth of these end-users of oxidative stress assays will drive the demand for these products and solutions during the forecast period.
Key vendors
- Abcam
- EMD Millipore
- Promega
- Qiagen
- Thermo Fisher Scientific
Other prominent vendors
- Amsbio
- Bio-Rad
- BioVision
- Cell Biolabs
- Cell Signaling Technology
- Enzo Biochem
- Genova Diagnostics
- Rel Assay Diagnostics
- Sigma-Aldrich
- tebu-bio
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by end-user
Part 08: Geographical segmentation
Part 09: Market drivers
Part 10: Impact of drivers
Part 11: Market challenges
Part 12: Impact of drivers and challenges
Part 13: Market trends
Part 14: Vendor landscape
Part 15: Key vendor analysis
For more information about this report visit http://www.researchandmarkets.com/research/98gvn3/global_oxidative
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biomarkers


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Anta Sports Expands Global Footprint With Strategic Puma Stake
Washington Post Publisher Will Lewis Steps Down After Layoffs
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



